Abstract
Invasive aspergillosis is the most common opportunistic fungal infection in the hematopoetic stem cell transplant patient. Prior to the regular use of antifungal prophylaxis, invasive fungal infections caused by Candida were the most common infection, followed by infection by Aspergillus.1 In the 1990s, 90% of Aspergillus infections were due to A. fumigatus; however A. flavus, A. terreus, A. niger, and A. versicolor are all potential causes of invasive aspergillosis. A. flavus, followed by A. niger, is the most common cause of primary cutaneous disease while A. fumigatus more commonly causes disseminated disease.2 A. glaucus, A. chevalieri, and A. ustus are rare causes of cutaneous disease.3
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aspergillosis
Kriengkauykiat J, Ito JI, Dadwal SS. Epidemiology and treatment approaches in management of invasive fungal infections. Clinical Epidemiology. 2011;3:175–191.
Nenoff P, Kliem C, Mittag M, et al. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur J Dermatol. 2002;12:93–8.
Roilides E, Farmaki E. Human immunodeficiency virus infection and cutaneous Aspergillosis. Arch Derm. 2000;136:412–4.
Murakawa GJ, Harvell JD, Lubitz P, et al. Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Derm. 2000;136:365–9.
Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infection in haematopoietic stem cell transplant recipients. Br J Hematol. 2007;139:519–31.
Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41:521–6.
Walsh TJ. Primary cutaneous aspergillosis – an emerging infection among immunocompromised patients. Clin Infect Dis. 1998;27:453–7.
Richards KA, Mancini AJ. A painful erythematous forearm nodule in a girl with Hodgkin disease. Diagnosis: primary cutaneous aspergillosis. Arch Dermatol. 2000;136(9):1165–70.
Grossman ME, Fithian EC, Behrens C, et al. Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol. 1985;12:313–8.
Munn S, Keane F, Child F, Philpott-Howard J, Du Vivier A. Primary cutaneous aspergillosis. Br J Dermatol. 1999;141:378–80.
Ricci RM, Evans JS, Meffert JJ, Kaufman L, Sadkowski LC. Primary cutaneous Aspergillus ustus infection: second reported case. J Am Acad Dermatol. 1998;38(5 Pt 2):797–8.
Chakrabarti A, Gupta V, Biswas G, Kumar B, Sakhuja VK. Primary cutaneous aspergillosis: our experience in 10 years. J Infect. 1998;37:24–7.
Vennewald I, Wollina U. Cutaneous infection due to opportunistic molds: uncommon presentations. Clin Dermatol. 2005;23:565–71.
Park SB, Kang MJ, Whang EA, et al. A case of primary cutaneous aspergillosis in a renal transplant recipient. Transplant Proc. 2004;36:2156–7.
Thakur BK, Bernardi DM, Murali MR, McClain SA, Clark RA. Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris. J Amer Acad Dermatol. 1998;38:488–90.
Mori T, Takae Y, Izaki S, et al. Cutaneous aspergillosis in a patient with follicular lymphoma. Eur J Dermatol. 2003;13:102–3.
Correa ME, Soares AB, de Souza CA, et al. Primary aspergillosis affecting the tongue of a leukemic patient. Oral Dis. 2003;9:49–53.
D’Antonio D, Pagano L, Girmenia C, et al. Cutaneous aspergillosis in patients with haematological malignancies. Eur J Clin Microbiol Infect Dis. 2000;19:362–5.
Palmero ML, Pope E, Brophy J. Sporotrichoid aspergillosis in an immunocompromised child: a case report and review of the literature. Pediatr Dermatol. 2009 ;26(5):592–6.
Geyer AS, Fox LP, Rabinowitz A, Grossman ME. Dehisced wound in a heart transplant recipient. Arch Dermatol. 2005;141(8):1037–40.
van Burik JA, Colven R, Spach DH. Itraconazole therapy for primary cutaneous aspergillosis in patients with AIDS. Clin Infect Dis. 1998;27:643–4.
Saadat P, Kappel S, Young S, Abrishami M, Vadmal MS. Aspergillus fumigatus majocchis granuloma in a patient with acquired immunodeficiency syndrome. Clin Exp Dermatol. 2008;33:450–3.
Stanford D, Boyle M, Gillespie R. Human immunodeficiency virus-related primary cutaneous aspergillosis. Australas J Dermatol. 2000;41:112–6.
Hunt SJ, Nagi C, Gross KG, Wong DS, Mathews WC. Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome. Arch Derm. 1992;128:1229–32.
Arikan S, Uzun O, Cetinkaya Y, et al. Primary cutaneous aspergillosis in human immunodeficiency virus-infected patients: two cases and review. Clin Infect Dis. 1998;27(3):641–3.
Schimmelpfennig C, Naumann R, Zuberbier T, et al. Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2001;27:753–5.
Nenoff P, Kliem C, Mittag M, et al. Secondary cutaneous aspergillosis due to Aspergillus flavus in an acute myeloid leukaemia patient following stem cell transplantation. Eur J Dermatol. 2002;12:93–8.
Galimberti R, Kowalczuk A, Hidalgo Parra I, Gonzalez Ramos M, Flores V. Cutaneous aspergillosis: a report of six cases. Br J Dermatol. 1998;139:522–6.
Szyfelbein K, Lin JY, Bellucci KS, Williams JM. Tender erythema of the left lower extremity. Disseminated Aspergillus fumigatus infection with concurrent active cytomegalovirus infection (CMV). Arch Dermatol. 2007;143:535–40.
Chatzipanagiotou S, Takou K, Perogamvros A. Cutaneous purulent aspergillosis in a young man with chronic granulomatous disease. Mycoses. 1998;41(9–10):379–82.
Keating MR, Guerrero MA, Daly RC, Walker RC, Davies SF. Transmission of invasive Aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest. 1996;109:1119–24.
Shao PL, Huang LM, Hsueh PR. Invasive fungal infection – laboratory diagnosis and antifungal treatment. J Microbiol Immunol Infect. 2006;39:178–88.
Blastomycosis
Hay RJ. Blastomycosis: what’s new? J Eur Acad Dermatol Venereol. 2000 ;14(4):249–50.
Bradsher RW. Clinical features of blastomycosis. Semin Respir Infect. 1997;12(3):229–34.
Pappas PG. Blastomycosis in the immunocompromised patient. Semin Respir Infect. 1997;12(3):243–51.
Cohen P, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.
Fisher KR, Baselski V, Beard G, et al. Pustular blastomycosis. J Am Acad Dermatol. 2009;61:355–8.
Smith JA, Kauffman CA. Endemic fungal infections in patients receiving tumor necrosis factor-alpha inhibitor therapy. Drugs. 2009;69:1403–15.
Serody JS, Mill MR, Detterbeck FC, Harris DT, Cohen MS. Blastomycosis in transplant recipients: report of a case and review. Clin Infect Dis. 1993;16(1):54–8.
Walker K, Skelton H, Smith K. Cutaneous lesions showing giant yeast forms of Blastomyces dermatitidis. J Cutan Pathol. 2002;29:616–8.
Lemos LB, Baliga M, Guo M. Blastomycosis: the Great Pretender can also be an opportunist. Initial clinical diagnosis and underlying diseases in 123 patients. Ann Diagn Pathol. 2002;6(3):194–203.
Gauthier GM, Safdar H, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310–7.
Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801–12.
Candidiasis
Pedraz J, Delgado-Jiménez Y, Pérez-Gala S, et al. Cutaneous expression of systemic candidiasis. Clin Exp Dermatol. 2009;34:106–10.
Bougnoux ME, Dupont C, Turner L, et al. Mixed Candida glabrata and Candida albicans disseminated candidiasis in a heroin addict. Eur J Clin Microbiol Infect Dis. 1997;16:598–600.
Kreuter A, Teichmann M, Stuecker M, et al. Generalized fungal infection in a patient with AIDS appearing as skin papules. Eur J Med Res. 2003;8:435–7.
Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol. 2002;3:19–35.
Leung AY, Chim CS, Ho PL, et al. Candida tropicalis fungaemia in adult patients with haematological malignancies: clinical features and risk factors. J Hosp Infect. 2002;50:316–9.
Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis. 2005;41:521–6.
Muñoz P, Sánchez-Somolinos M, Alcalá L, et al. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital. J Antimicrob Chemother. 2005;55:188–93.
Gunsilius E, Lass-Flörl C, Kähler CM, Gastl G, Petzer AL. Candida ciferrii, a new fluconaozle-resistant yeast causing systemic mycosis in immunocompromised patients. Ann Hematol. 2001;80:178–9.
Wellinghausen N, Moericke A, Bundschuh S, et al. Multifocal osteomyelitis caused by Candida dubliniensis. J Med Microbiol. 2009;58:386–90.
Bodey GP. Dermatologic manifestations of infections in neutropenic patients. Infect Dis Clin North Am. 1994;8:655–75.
Grossman ME, Silvers DN, Walther RR. Cutaneous manifestations of disseminated candidiasis. J Am Acad Dermatol. 1980;2:111–6.
Ruchel R. Clinical presentation of invasive candida mycoses. Mycoses. 1997;40:17–20.
Wai PH, Ewing CA, Johnson LB, et al. Candida fasciitis following renal transplantation. Transplantation. 2001;72(3):477–9.
Glaich AS, Krathen RA, Smith MJ, Hsu S. Disseminated candidiasis mimicking leukocytoclastic vasculitis. J Am Acad Dermatol. 2005;53(3):544–6.
Marcus J, Grossman ME, Yunakov MJ, Rappaport F. Disseminated candidiasis, candida arthritis and unilateral skin lesions. J Am Acad Dermatol. 1992;26:295–7.
Held JL, Berkowitz RK, Grossman ME. Use of touch preparation for rapid diagnosis of disseminated candidiasis. J Am Acad Dermatol. 1988;19:1063–6.
Spellberg BJ, Filler SG, Edwards Jr JE. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42(2):244–51. Epub 2005 Dec 2.
Coccidioidomycosis
DiCaudo DJ. Coccidioidomycosis: a review and update. J Am Acad Dermatol. 2006;55(6):929–42.
Santelli AC, Blair JE, Roust LR. Coccidioidomycosis in patients with diabetes mellitus. Am J Med. 2006;119(11):964–9.
Bergstrom L, Yocum DE, Ampel NM, et al. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum. 2004;50(6):1959–66.
Prichard JG, Sorotzkin RA, James III RE. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis. 1987;39(3):203–5.
Stagliano D, Epstein J, Hickey P. Fomite-transmitted coccidioidomycosis in an immunocompromised child. Pediatr Infect Dis J. 2007;26(5):454–6.
Braddy CM, Heilman RL, Blair JE. Coccidioidomycosis after renal transplantation in an endemic area. Am J Transplant. 2006;6(2):340–5.
Vartivarian SE, Coudron PE, Markowitz SM. Disseminated coccidioidomycosis. Unusual manifestations in a cardiac transplantation patient. Am J Med. 1987;83(5):949–52.
Wolf JE, Little JR, Pappagianis D, Kobayashi GS. Disseminated coccidioidomycosis in a patient with the acquired immune deficiency syndrome. Diagn Microbiol Infect Dis. 1986;5(4):331–6.
Rogan MP, Thomas K. Fatal miliary coccidioidomycosis in a patient receiving infliximab therapy: a case report. J Med Case Rep. 2007;1:79.
Poonawalla T, Diwan H, Duvic M. Mycosis fungoides with coccidioidomycosis. Clin Lymphoma Myeloma. 2006;7(2):148–50.
Ugurlu S, de Alba Campomanes AG, Naseri A, Blair JE, McLeish WM. Coccidioidomycosis of the eyelid. Ophthal Plast Reconstr Surg. 2005;21(2):157–9.
Gold WL, Campbell I, Vellend H. Disseminated coccidioidomycosis in a Canadian patient with chronic HIV infection – Ontario. Can Commun Dis Rep. 1992;18(19):149–50.
Blair JE. Coccidioidomycosis in patients who have undergone transplantation. Ann N Y Acad Sci. 2007;1111:365–76.
Ampel NM. Coccidioidomycosis among persons with human immunodeficiency virus infection in the era of highly active antiretroviral therapy (HAART). Semin Respir Infect. 2001;16(4):257–62.
Cryptococcosis
Narayan S, Batta K, Colloby P, Tan CY. Cutaneous Cryptococcus infection due to C. albidus associated with SeÂzary syndrome. Br J Dermatol. 2000;143:632–4.
Cohen P, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.
Sing Y, Ramdial PK. Cryptococcal inflammatory pseudotumors. Am J Surg Pathol. 2007;31:1521–7.
França AV, Carneiro M, dal Sasso K, Souza Cda S, Martinelli A. Cryptococcosis in cirrhotic patients. Mycoses. 2005;48:68–72.
Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375–81.
Orsini J, Nowakowski J, Delaney V, Sakoulas G, Wormser GP. Cryptococcal infection presenting as cellulitis in a renal transplant recipient. Transpl Infect Dis. 2009;11:68–71.
Moe K, Lotsikas-Baggili AJ, Kupiec-Banasikowska A, Kauffman CL. The cutaneous predilection of disseminated cryptococcal infection in organ transplant recipients. Arch Dermatol. 2005;141(7):913–4.
Christianson JC, Engber W, Andes D. Primary cutaneous cryptococcosis in immunocompetent and immunocompromised hosts. Med Mycol. 2003;41(3):177–88.
Wilson ML, Sewell LD, Mowad CM. Case reports: primary cutaneous Cryptoccocosis during therapy with methotrexate and adalimumab. J Drugs Dermatol. 2008;7:53–4.
Hoang JK, Burruss J. Localized cutaneous Cryptococcus albidus. Infection in a 14-year-old boy on etanercept therapy. Pediatr Dermatol. 2007;24(3):285–8.
Murakawa GJ, Kerschmann R, Berger T. Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature. Arch Derm. 1996;132:545–8.
Sánchez P, Bosch RJ, de Gálvez MV, Gallardo MA, Herrera E. Cutaneous cryptococcosis in two patients with acquired immunodeficiency syndrome. Int J STD AIDS. 2000;11:477–80.
Gasiorowski J, Knysz B, Szetela B, Gładysz A. Cutaneous cryptococcosis as a rare manifestation of the immune reconstitution syndrome in an HIV-1-infected patient. Postepy Hig Med Dosw (Online). 2008;62:1–3.
Vandersmissen G, Meuleman L, Tits G, Verhaeghe A, Peetermans WE. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin Belg. 1996;51(2):111–7.
Adachi M, Tsuruta D, Imanishi H, Ishii M, Kobayashi H. Necrotizing fasciitis caused by Cryptococcus neoformans in a patient with pemphigus vegetans. Clin Exp Dermatol. 2009;34(8):751–3.
Başaran O, Emiroğlu R, Arikan U, Karakayali H, Haberal M. Cryptococcal necrotizing fasciitis with multiple sites of involvement in the lower extremities. Dermatol Surg. 2003;29(11):1158–60.
Baer S, Baddley JW, Gnann JW, Pappas PG. Cryptococcal disease presenting as necrotizing cellulitis in transplant recipients. Transpl Infect Dis. 2009;11(4):353–8.
Carbia SG, Chain M, Acuña K, et al. Disseminated cryptococcosis with cutaneous lesions complicating steroid therapy for Behçet’s disease. Int J Dermatol. 2003;42:816–8.
Blocher KS, Weeks JA, Noble RC. Cutaneous cryptococcal infection presenting as vulvar lesion. Genitourin Med. 1987;63:341–3.
Ebara N, Kobayashi N, Asaka H, et al. Localized cutaneous cryptococcosis in a patient with chronic myeloproliferative disease. J Dermatol. 2005;32(8):674–6.
Manfredi R, Mazzoni A, Nanetti A, et al. Morphologic features and clinical significance of skin involvement in patients with AIDS-related cryptococcosis. Acta Derm Venereol. 1996;76(1):72–4.
Dimino-Emme L, Gurevitch AW. Cutaneous manifestations of disseminated cryptococcosis. J Am Acad Dermatol. 1995;32:844–50.
Calista D, Grosso C. Cutaneous cryptococcosis of the penis. Dermatol Online J. 2008;14(7):9.
Hecker MS, Weinberg JM. Cutaneous cryptococcosis mimicking keloid. Dermatology. 2001;202:78–9.
Murakawa GJ, Mauro TM, Egbert B. Disseminated cutaneous Cryptococcus clinically mimicking basal cell carcinoma. Dermatol Surg. 1995;21(11):992–3.
Ingleton R, Koestenblatt E, Don P, et al. Cutaneous cryptococcosis mimicking basal cell carcinoma in a patient with AIDS. J Cutan Med Surg. 1998;3(1):43–5.
Annam V, Inamadar AC, Palit A, Yelikar BR. Co-infection of molluscum contagiosum virus and cryptococcosis in the same skin lesion in a HIV-infected patient. J Cutan Pathol. 2008;35 Suppl 1:29–31.
Myers SA, Kamino H. Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. J Am Acad Dermatol. 1996;34:898–900.
Neuville S, Dromer F, Morin O, et al. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis. 2003;36:337–47.
Zorman JV, Zupanc TL, Parač Z, Cuček I. Primary cutaneous cryptococcosis in a renal transplant recipient: case report. Mycoses. 2010;53(6):535–7.
Hunger RE, Paredes BE, Quattroppani C, Krähenbühl S, Braathen LR. Primary cutaneous cryptococcosis in a patient with systemic immunosuppression after liver transplantation. Dermatology. 2000;200:352–5.
Baumgarten KL, Valentine VG, Garcia-Diaz JB. Primary cutaneous cryptococcosis in a lung transplant recipient. South Med J. 2004;97:692–5.
Badreshia S, Klepeiss S, Ioffreda M, et al. Cutaneous cryptococcus in an elderly woman with chronic essential dermatitis. Cutis. 2006;78:53–6.
Romano C, Taddeucci P, Donati D, Miracco C, Massai L. Primary cutaneous cryptococcosis due to Cryptococcus neoformans in a woman with non-Hodgkin’s lymphoma. Acta Dermatol Venerol. 2001;8:220–1.
Bohne T, Sander A, Pfister-Wartha A, Schöpf E. Primary cutaneous cryptococcosis following trauma of the right forearm. Mycoses. 1996;39(11–12):457–9.
Ramdial PK, Calonje E, Sing Y, Chotey NA, Aboobaker J. Molluscum-like cutaneous cryptococcosis: a histopathological and pathogenetic appraisal. J Cutan Pathol. 2008;35:1007–13.
Histoplasmosis
Bonifaz A, Chang P, Moreno K, Fernández-Fernández V, et al. Disseminated cutaneous histoplasmosis in acquired immunodeficiency syndrome: report of 23 cases. Clin Exp Dermatol. 2009;34(4):481–6.
Couppié P, Clyti E, Nacher M, et al. Acquired immunodeficiency syndrome-related oral and/or cutaneous histoplasmosis: a descriptive and comparative study of 21 cases in French Guiana. Int J Dermatol. 2002;41:571–6.
Cohen PR, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.
Cohen PR, Grossman ME, Silvers DN. Disseminated histoplasmosis and human immunodeficiency virus infection. Int J Dermatol. 1991;30(9):614–22.
Cohen PR, Bank DE, Silvers DN, Grossman ME. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol. 1990;23(3 Pt 1):422–8.
Cunha VS, Zampese MS, Aquino VR, Cestari TF, Goldani LZ. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol. 2007;32:250–5.
Cohen PR, Held JL, Grossman ME, Ross MJ, Silvers DN. Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in a human immunodeficiency virus-infected man. Report of a case possibly involving human-to-human transmission of histoplasmosis. Int J Dermatol. 1991;30(2):104–8.
Kucharski LD, Dal Pizzol AS, Fillus J Neto, et al. Disseminated cutaneous histoplasmosis and AIDS: case report. Braz J Infect Dis. 2000;4(5):255–61.
Kalter DC, Tschen JA, Klima M. Maculopapular rash in a patient with acquired immunodeficiency syndrome. Disseminated histoplasmosis in acquired immunodeficiency syndrome (AIDS). Arch Dermatol. 1985;121(11):1455–6, 1458–9.
Laochumroonvorapong P, DiCostanzo DP, Wu H, et al. Disseminated histoplasmosis presenting as pyoderma gangrenosum-like lesions in a patient with acquired immunodeficiency syndrome. Int J Dermatol. 2001;40(8):518–21.
K Ramdial P, Mosam A, Dlova NC, et al. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2002;29:215–25.
Chaker BM, Cockerell CJ. Concomitant psoriasis, seborrheic dermatitis, and disseminated cutaneous histoplasmosis in a patient infected with human immunodeficiency virus. J Am Acad Dermatol. 1993;29(2 Pt 2):311–3.
Abildgaard Jr WH, Hargrove RH, Kalivas J. Histoplasma panniculitis. Arch Dermatol. 1985;121(7):914–6.
Rosenberg JD, Scheinfeld NS. Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome. Cutis. 2003;72(6):439–45.
Cole MC, Cohen PR, Satra KH, Grossman ME. The concurrent presence of systemic disease pathogens and cutaneous Kaposi’s sarcoma in the same lesion: histoplasma capsulatum and Kaposi’s sarcoma coexisting in a single skin lesion in a patient with AIDS. J Am Acad Dermatol. 1992;26(2 Pt 2):285–7.
Myers SA, Kamino H. Cutaneous cryptococcosis and histoplasmosis coinfection in a patient with AIDS. J Am Acad Dermatol. 1996;34:898–900.
Cole MC, Grossman ME. Disseminated histoplasmosis presenting as tongue nodules in an HIV infected patient. Cutis. 1995;55:104–6.
Casariego Z, Kelly GR, Perez H, et al. Disseminated histoplasmosis with orofacial involvement in HIV-1-infected patients with AIDS: manifestations and treatment. Oral Dis. 1997;3:184–7.
Barton EN, Roberts L, Ince WE, et al. Cutaneous histoplasmosis in the acquired immune deficiency syndrome – a report of three cases from Trinidad. Trop Geogr Med. 1988;40(2):153–7.
de Oliveira EV, Miduati FB, Antonio JR, et al. Histoplasmosis as cause of penile ulcer in acquired immune deficiency syndrome (AIDS): three case reports. Mycopathologia. 2007;164:295–9.
Rodríguez G, Ordóñéz N, Motta A. Histoplasma capsulatum var. capsulatum within cutaneous nerves in patients with disseminated histoplasmosis and AIDS. Br J Dermatol. 2001;144(1):205–7.
Paul AY, Aldrich S, Scott RS, Ellis MW. Disseminated histoplasmosis in a patient with AIDS: case report and review of the literature. Cutis. 2007;80(4):309–12.
Breton G, Adle-Biassette H, Therby A, et al. Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis. AIDS. 2006;20(1):119–21.
Phaeohyphomycosis
Foulet F, Duvoux C, de Bièvre C, Hézode C, Bretagne S. Cutaneous phaeohyphomycosis caused by Veronaea bothryosa in a liver transplant recipient successfully treated with itraconazole. Clin Infect Dis. 1999;29(3):689–90.
Liou JM, Wang JT, Wang MH, Wang SS, Hsueh PR. Phaeohyphomycosis caused by Exophiala species in immunocompromised hosts. J Formos Med Assoc. 2002;101(7):523–6.
Umemoto N, Demitsu T, Kakurai M, et al. Two cases of cutaneous phaeohyphomycosis due to exophiala jeanselmei: diagnostic significance of direct microscopic examination of the purpulent discharge. Clin Exp Dermatol. 2009;34(7):e351–3.
Singh N, Chang FY, Gayowski T, Marino IR. Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997;24(3):369–74.
Saint-Jean M, St-Germain G, Laferrière C, Tapiero B. Hospital-acquired phaeohyphomycosis due to Exserohilum rostratum in a child with leukemia. Can J Infect Dis Med Microbiol. 2007;18(3):200–2.
Sutton DA, Rinaldi MG, Kielhofner M. First U.S. report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J Clin Microbiol. 2004;42:2843–6.
Gerdsen R, Uerlich M, De Hoog GS, Bieber T, Horré R. Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol. 2001;154:484–6.
Calabrò G, Nino M, Gallo L, Scalvenzi M. Cutaneous alternariosis in a kidney transplantation recipient: report of a case. J Dermatolog Treat. 2008;19:246–8.
Lin SC, Sun PL, Ju YM, Chan YJ. Cutaneous phaeohyphomycosis caused by Exserohilum rostratum in a patient with cutaneous T cell lymphoma. Int J Dermatol. 2009;48:295–8.
Segner S, Jouret F, Durant JF, Marot L, Kanaan N. Cutaneous infection by Alternaria infectoria in a renal transplant patient. Transpl Infect Dis. 2009;11:330–2.
Martínez-González MC, Verea MM, Velasco D, et al. Three cases of cutaneous phaeohyphomycosis by Exophiala jeanselmei. Eur J Dermatol. 2008;18(3):313–6.
Brasch J, Busch JO, de Hoog GS. Cutaneous phaeohyphomycosis caused by Alternaria infectoria. Acta Derm Venereol. 2008;88:160–1.
Romano C, Bilenchi R, Alessandrini C, Miracco C. Case report. Cutaneous phaeohyphomycosis caused by Cladosporium oxysporum. Mycoses. 1999;42:111–5.
Gené J, Azón-Masoliver A, Guarro J, et al. Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient. J Clin Microbiol. 1995;33:2774–6.
Harris JE, Sutton DA, Rubin A, et al. Exophiala spinifera as a cause of cutaneous phaeohyphomycosis: case study and review of the literature. Med Mycol. 2009;47(1):87–93.
Dubois D, Pihet M, Clec’h CL, et al. Cutaneous phaeohyphomycosis due to Alternaria infectoria. Mycopathologica. 2005;160:117–23.
Yehia M, Thomas M, Pilmore H, Van Der Merwe W, Dittmer I. Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients: three cases. Transplantation. 2004;77:140–2.
McCown HF, Sahn EE. Subcutaneous phaeohyphomycosis and nocardiosis in a kidney transplant patient. J Am Acad Dermatol. 1997;36(5 Pt 2):863–6.
Arnoldo BD, Purdue GF, Tchorz K, Hunt JL. A case report of phaeohyphomycosis caused by Cladophialophora bantiana treated in a burn unit. J Burn Care Rehabil. 2005;26:285–7.
O’Quinn RP, Hoffmann JL, Boyd AS. Colletotrichum species as emerging opportunistic fungal pathogens: a report of 3 cases of phaeohyphomycosis and review. J Am Acad Dermatol. 2001;45(1):56–61.
Pereiro Jr M, Pereiro Ferreirós MM, De Hoog GS, Toribio J. Cutaneous infection caused by Alternaria in patients receiving tacrolimus. Med Mycol. 2004;42(3):277–82.
Mayser P, Nilles M, de Hoog GS. Case report. Cutaneous phaeohyphomycosis due to Alternaria alternata. Mycoses. 2002; 45(8):338–40.
Al-Attar A, Williams CG, Redett RJ. Rare lower extremity invasive fungal infection of an immunosuppressed patient: Exserohilum longirostratum. Plast Reconstr Surg. 2006;117(3):44e–7e.
Chen YT, Lin HC, Huang CC, Lo YH. Cutaneous phaeohyphomycosis caused by an Itraconazole and Amphotericin B resistant strain of Veronaeae botryose. Int J Dermatol. 2006;45:429–32.
Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467–76.
Ohira S, Isoda K, Hamanaka H, et al. Case report. Phaeohyphomycosis caused by Phialophera verrucosa developed in a patient with non-HIV acquired immunodeficiency syndrome. Mycoses. 2002;45(1–2):50–4.
Keyser A, Schmid FX, Linde HJ, Merk J, Birnbaum DE. Disseminated Cladophialophora bantiana infection in a heart transplant recipient. J Heart Lung Transplant. 2002;21:503–5.
Levy I, Stein J, Ashkenazi S, et al. Ecthyma gangrenosum caused by disseminated Exserohilum in a child with leukemia: case report and review of the literature. Pediatr Dermatol. 2003;20:495–7.
Scedosporium and Pseudallescheria
Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008;21(1):157–97.
Husain S, Muñoz P, Forrest G, et al. Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. Clin Infect Dis. 2005;40(1):89–99.
Ginter G, de Hoog GS, Pschaid A, et al. Arthritis without grains caused by Pseudallescheria boydii. Mycoses. 1995;38(9–10):369–71.
Bower CP, Oxley JD, Campbell CK, Archer CB. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient. J Clin Pathol. 1999;52(11):846–8.
Lavigne C, Maillot F, de Muret A, et al. Cutaneous infection with Scedosporium apiospermum in a patient treated with corticosteroids. Acta Derm Venereol. 1999;79(5):402–3.
Talbot TR, Hatcher J, Davis SF, et al. Scedosporium apiospermum pneumonia and sternal wound infection in a heart transplant recipient. Transplantation. 2002;74(11):1645–7.
Lainscak M, Hocevar A, Logar D, et al. Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient. Clin Rheumatol. 2007;26:1023–4.
Uenotsuchi T, Moroi Y, Urabe K, et al. Cutaneous Scedosporium apiospermum infection in an immunocompromised patient and a review of the literature. Acta Derm Venereol. 2005;85(2):156–9.
Castiglioni B, Sutton DA, Rinaldi MG, Fung J, Kusne S. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002;81(5):333–48.
Chaveiro MA, Vieira R, Cardoso J, Afonso A. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient. J Eur Acad Dermatol Venereol. 2003;17(1):47–9.
Shinohara MM, George E. Scedosporium apiospermum an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes. J Cutan Pathol. 2009;36 Suppl 1:39–41.
Kusuhara M, Hachisuka H. Lymphocutaneous infection due to Scedosporium apiospermum. Int J Dermatol. 1997;36(9):684–8.
Ruxin TA, Steck WD, Helm TN, Bergfeld WF, Bolwell BJ. Pseudallescheria boydii in an immunocompromised host. Successful treatment with debridement and itraconazole. Arch Dermatol. 1996;132(4):382–4.
Hagari Y, Ishioka S, Ohyama F, Mihara M. Cutaneous infection showing sporotrichoid spread caused by Pseudallescheria boydii (Scedosporium apiospermum): successful detection of fungal DNA in formalin-fixed, paraffin-embedded sections by seminested PCR. Arch Dermatol. 2002;138(2):271–2.
Török L, Simon G, Csornai A, Tápai M, Török I. Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukaemia. Br J Dermatol. 1995;133(5):805–9.
Bernstein EF, Schuster MG, Stieritz DD, Heuman PC, Uitto J. Disseminated cutaneous Pseudallescheria boydii. Br J Dermato. 1995;132(3):456–60.
Barbaric D, Shaw PJ. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole. Med Pediatr Oncol. 2001;37(2):122–5.
Elm MK, Ahmed A, Gokselo D, Heming JS. Cutaneous and systemic infection with Scedosporium apiospermum. Cutis. 2009;84:275–8.
Berenguer J, Rodríguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore). 1997;76(4):256–65.
Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47(4):359–70.
Sporotrichosis
Dong JA, Chren MM, Elewski BE. Bonsai tree: risk factor for disseminated sporotrichosis. J Am Acad Dermatol. 1995;33:839–40.
Cohen PR, Grossman ME, Silvers DN. Mucocutaneous manifestations of systemic fungal infections in the HIV-seropositive patient. AIDS Read. 1993;3:47–60.
Yang DJ, Krishnan RS, Guillen DR, et al. Disseminated sporotrichosis mimicking sarcoidosis. Int J Dermatol. 2006;45:450–3.
Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25(2):181–7.
al-Tawfiq JA, Wools KK. Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection. Clin Infect Dis. 1998;26(6):1403–6.
Bonifaz A, Peniche A, Mercadillo P, Saúl A. Successful treatment of AIDS-related disseminated cutaneous sporotrichosis with itraconazole. AIDS Patient Care STDS. 2001;15(12):603–6.
Carvalho MT, de Castro AP, Baby C, et al. Disseminated cutaneous sporotrichosis in a patient with AIDS: report of a case. Rev Soc Bras Med Trop. 2002;35(6):655–9.
Sharma NL, Mehta KI, Mahajan VK, et al. Cutaneous sporotrichosis of face: polymorphism and reactivation after intralesional triamcinolone. Indian J Dermatol Venereol Leprol. 2007;73(3):188–90.
Donabedian H, O’Donnell E, Olszewski C, MacArthur RD, Budd N. Disseminated cutaneous and meningeal sporotrichosis in an AIDS patient. Diagn Microbiol Infect Dis. 1994;18(2):111–5.
Yelverton CB, Stetson CL, Bang RH, Clark JW, Butler DF. Fatal sporotrichosis. Cutis. 2006;78(4):253–6.
Kim S, Rusk MH, James WD. Erysipeloid sporotrichosis in a woman with Cushing’s disease. J Am Acad Dermatol. 1999;40:272–4.
Rocha MM, Dassin T, Lira R, et al. Sporotrichosis in patient with AIDS: report of a case and review. Rev Iberoam Micol. 2001;18(3):133–6.
Fontes PC, Kitakawa D, Carvalho YR, et al. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol. 2007;51(4):648–50.
Aarestrup FM, Guerra RO, Vieira BJ, Cunha RM. Oral manifestation of sporotrichosis in AIDS patients. Oral Dis. 2001;7(2):134–6.
Johnson RA. HIV disease: mucocutaneous fungal infections in HIV disease. Clin Dermatol. 2000;18(4):411–22.
Silva-Vergara ML, Maneira FR, De Oliveira RM, et al. Multifocal sporotrichosis with meningeal involvement in a patient with AIDS. Med Mycol. 2005;43(2):187–90.
Severo LC, Festugato M, Bernardi C, Londero AT. Widespread cutaneous lesions due to Sporothrix schenckii in a patient under a long-term steroids therapy. Rev Inst Med Trop Sao Paulo. 1999;41(1):59–62.
Hardman S, Stephenson I, Jenkins DR, Wiselka MJ, Johnson EM. Disseminated Sporothix schenckii in a patient with AIDS. J Infect. 2005;51(3):e73–7.
Vilela R, Souza GF, Fernandes Cota G, Mendoza L. Cutaneous and meningeal sporotrichosis in a HIV patient. Rev Iberoam Micol. 2007;24(2):161–3.
Bickley LK, Berman IJ, Hood AF. Fixed cutaneous sporotrichosis: unusual histopathology following intralesional corticosteroid administration. J Am Acad Dermatol. 1985;12(6):1007–12.
Ware AJ, Cockerell CJ, Skiest DJ, Kussman HM. Disseminated sporotrichosis with extensive cutaneous involvement in a patient with AIDS. J Am Acad Dermatol. 1999;40(2 Pt 2):350–5.
Zygomycosis/Mucormycosis
Moraru RA, Grossman ME. Palatal necrosis in an AIDS patient: a case of mucormycosis. Cutis. 2000;66(1):15–8.
Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S. Zygomycosis and HIV infection. J Am Acad Dermatol. 1994;30(5 Pt 2):904–8.
Samant JS, Namgoong SH, Parveen T, Katner HP. Cytomegalovirus vasculitis and mucormycosis coinfection in late-stage HIV/AIDS. Am J Med Sci. 2007;333(2):122–4.
Mitchell SJ, Gray J, Morgan ME, Hocking MD, Durbin GM. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet. 1996;348(9025):441–3.
Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol. 2007;139(4):519–31.
Ramos A, Cuervas-Mons V, Noblejas A, et al. Breakthrough rhinocerebral mucormycosis in a liver transplant patient receiving caspofungin. Transplant Proc. 2009;41(5):1972–5.
Fujimoto A, Nagao K, Tanaka K, et al. The first case of cutaneous mucormycosis caused by Rhizopus azygosporus. Br J Dermatol. 2005;153(2):428–30.
Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:15–20.
Takabayashi M, Sakai R, Sakamoto H, et al. Cutaneous mucormycosis during induction chemotherapy for acute lymphocytic leukemia. Leuk Lymphoma. 2004;45(1):199–200.
Wirth F, Perry R, Eskenazi A, Schwalbe R, Kao G. Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature. J Am Acad Dermatol. 1997;36(2 Pt 2):336–41.
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.
Rubin AI, Grossman ME. Bull’s-eye cutaneous infarct of zygomycosis: a bedside diagnosis confirmed by touch preparation. J Am Acad Dermatol. 2004;51:996–1001.
Alsuwaida K. Primary cutaneous mucormycosis complicating the use of adhesive tape to secure the endotracheal tube. Can J Anaesth. 2002;49(8):880–2.
Woods SG, Elewski BE. Zosteriform zygomycosis. J Am Acad Dermatol. 1995;32(2 Pt 2):357–61.
Skiada A, Petrikkos G. Cutaneous zygomycosis. Clin Microbiol Infect. 2009;15 Suppl 5:41–5.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Grossman, M.E., Fox, L.P., Kovarik, C., Rosenbach, M. (2012). Subcutaneous and Deep Mycoses. In: Cutaneous Manifestations of Infection in the Immunocompromised Host. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1578-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1578-8_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1577-1
Online ISBN: 978-1-4419-1578-8
eBook Packages: MedicineMedicine (R0)